Abbott Sues Impax Over Depakote
Abbott Laboratories filed a patent suit Monday against generics maker Impax Laboratories Inc., increasing its efforts to protect the multimillion-dollar U.S. market for its epilepsy and migraine treatment Depakote....To view the full article, register now.
Already a subscriber? Click here to view full article